Valentina Bertaina - Concepedia

Author

Valentina Bertaina

Bambino Gesù Children's Hospital ORCID

Also Known As

V Bertaina, V. Bertaina, Valentina Bertaina

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Bambino Gesù Children's Hospital Istituti di Ricovero e Cura a Carattere Scientifico Sapienza University of Rome University of Pavia Istituto Giannina Gaslini

About

Valentina Bertaina is an author at Bambino Gesù Children's Hospital specializing in immunology, medicine, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	238
2	Immunology	5	5	238
3	Cell Biology	4	4	185
4	Health Sciences	1	1	11
5	Blood Transplantation	1	1	53

Valentina Bertaina

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma Francesca Del Bufalo, Biagio De Angelis, Ignazio Caruana, New England Journal of Medicine	2023	482
Outcome of children with acute leukemia given HLA-haploidentical HSCT after αβ T-cell and B-cell depletion Franco Locatelli, Pietro Merli, Daria Pagliara, Blood	2017	313
Unrelated donor vs HLA-haploidentical α/β T-cell– and B-cell–depleted HSCT in children with acute leukemia Alice Bertaina, Marco Zecca, Barbara Buldini, Blood	2018	130
Indoleamine 2,3-dioxygenase 1 (IDO1) activity in leukemia blasts correlates with poor outcome in childhood acute myeloid leukemia Valentina Folgiero, Bianca Maria Goffredo, Perla Filippini, Oncotarget Hematological MalignancyTryptophan ConsumptionPoor OutcomeLeukemia BlastsAcute Myeloid Leukemia	2013	106
The combination of bortezomib with chemotherapy to treat relapsed/refractory acute lymphoblastic leukaemia of childhood Alice Bertaina, Luciana Vinti, Luisa Strocchio, British Journal of Haematology	2017	69
Expansion of CD4dimCD8+ T cells characterizes macrophage activation syndrome and other secondary HLH Arianna De Matteis, Manuela Colucci, Marianna Nicoletta Rossi, Blood	2022	69
TCRαβ/CD19 depleted HSCT from an HLA-haploidentical relative to treat children with different nonmalignant disorders Pietro Merli, Daria Pagliara, Federica Galaverna, Blood Advances HistocompatibilityImmunologyTransplantation MedicineNmds PatientsImmunotherapy	2021	53
IDO1 involvement in mTOR pathway: a molecular mechanism of resistance to mTOR targeting in medulloblastoma Valentina Folgiero, Evelina Miele, Andrea Carai, Oncotarget Rapamycin TreatmentImmunologyImmune RegulationPathologyImmunoediting	2016	41
Allogeneic, donor-derived, second-generation, CD19-CAR-T cell for the treatment of pediatric relapsed/refractory BCP-ALL Francesca Del Bufalo, Marco Becilli, Chiara Rosignoli, Blood	2023	36
TCRαβ/CD19 cell–depleted HLA-haploidentical transplantation to treat pediatric acute leukemia: updated final analysis Pietro Merli, Mattia Algeri, Federica Galaverna, Blood	2023	36

Page 1